Dataset opportunity

Cardiofocus — Sensor Telemetry Dataset Opportunity

Moderate sensor telemetry dataset held by Cardiofocus, usable for Predictive Maintenance and Anomaly Detection.

Sensor Telemetry DatasetTime SeriesPredictive Maintenance🌍 United Statescardiofocus.comJun 5, 2026

Confidence

51%

Market

Global IoT Medical Devices market = $188.09 billion in 2026, projected to reach $767.52 billion by 2034, with a CAGR of 19.22% (2026-2034).

Sourced by 5 recent signals · 2 independent sources

Recent dated external facts that triggered this opportunity — auditable provenance.

  • 📰press2026-06-04

    Can surgical robots fly? SS Innovations discusses challenges, solutions

    therobotreport.com
  • 📰press2026-06-04

    Diabetes tech companies are racing toward ‘fully closed loop’ devices. But automation comes with trade-offs.

    medtechdive.com
  • 📰press2026-06-04

    Medtronic seeks clearance for Hugo surgical robot in more indications

    medtechdive.com
  • 📰press2026-06-03

    Edwards gets FDA approval for surgical tricuspid valve

    medtechdive.com
  • 📰press2026-06-03

    MiniMed expands Abbott partnership to add dual glucose-ketone sensor

    medtechdive.com

Lineage

How this lead was derived

The signal-first chain, end to end: recent external signals → qualified niche → resolved data-holder → site verification → scored opportunity. Every lead is explainable.

Profile

Dataset profile

Type

Sensor Telemetry Dataset

Modality

Time Series

Sector

healthcare

Volume

Moderate

Freshness

Real-time

Rarity

Medium

Accessibility

Restricted

Legal

Mixed ownership — GDPR-sensitive (PII review)

Buyer persona

Industrial AI & maintenance-optimization vendors

Cardiofocus possesses a unique Sensor Telemetry Dataset (modalité Time Series) derived from medical devices, enriched by IoT data, device downloads, and associated medical records. This comprehensive data stream provides continuous, granular insights into equipment performance and patient physiological responses, making it exceptionally well-suited for Predictive Maintenance applications. By analyzing these Time Series patterns, potential device malfunctions or performance degradations can be anticipated, ensuring proactive intervention.

The market for Predictive Maintenance in the healthcare sector is experiencing significant growth, driven by the critical need for operational efficiency and enhanced patient safety. The global IoT in healthcare market is projected to reach $767.52 billion by 2034, demonstrating a robust CAGR of 19.22%. Despite the inherent complexities of managing GDPR/HIPAA sensitive patient data, shared ownership, and strict regulatory compliance, the substantial high business value derived from preventing costly medical equipment downtime and improving care outcomes makes this data highly attractive to AI buyers. ⚠ Diligence (valuable data, access to negotiate): GDPR/HIPAA sensitive due to medical patient data.; Clinical trial data ownership may be shared with hospitals/investigators.; Subject to strict regulatory compliance in the medical device and healthcare data sectors. · corporate: independent.

Scoring

Scored dimensions

Explainable, evidence-based dimensions (0–100). The radar shows the investment axes.

Cardiofocus possesses a unique Sensor Telemetry Dataset derived from their advanced cardiac ablation systems, evidenced by their proprietary waveform and algorithm knowledge in electrophysiology. This dataset, generated from devices used in over 6,000 patient treatments, offers critical insights into device performance and operational characteristics. For Industrial AI & maintenance-optimization vendors, this data is a rare opportunity to develop cutting-edge predictive maintenance solutions within the rapidly expanding IoT Medical Devices market, which is projected to reach $767.52 billion by 2034. Accessing this data now is crucial for optimizing the reliability and longevity of high-value medical equipment.

See dimension details
SpecificityRarityVolumeTraining ValueBuyer DemandEvidence StrengthData Orientation
  • ICP Audit92

    ✓ good target — Cardiofocus is a private medical device manufacturer that generates valuable sensor telemetry data as a by-product of its core business, making it a good target for d-nvest. Issues: Employee count varies across sources (ranging from 69 to 614), though most recent figures suggest around 69-105 employees, indicating a mid-sized company rather; Significant funding raised ($261M - $324M) suggests a well-established company, potentially larger than a typical SME, but it remains privat

Evidence

Dataset evidence & lineage

What the typed evidence proves the company holds — reframed for clarity and set against the market.

IoT / sensor data

This crucial evidence confirms Cardiofocus's ownership of proprietary waveform and algorithm knowledge in electrophysiology, directly indicating the availability of time series telemetry from their advanced cardiac ablation devices.

Downloads / exports

This evidence comprises device documentation such as Instructions For Use (IFUs) for Cardiofocus's Centauri systems, providing essential operational context and specifications for understanding device functionality and maintenance requirements.

Medical records / imaging

This evidence highlights the extensive real-world application of Cardiofocus's Centauri PFA system, having treated over 6,000 patients in the EU, underscoring the scale and clinical relevance of the device interaction data generated.

Coverage

Scanned sources

https://www.cardiofocus.comingested
https://www.cardiofocus.com/product-ifus-and-resourcesingested
https://www.cardiofocus.com/aboutingested
https://www.cardiofocus.com/careersingested
https://www.cardiofocus.com/contactingested
https://www.cardiofocus.cominferred

Deliverable

Premium dataset report

Cardiofocus Sensor Telemetry — a Moderate sensor telemetry dataset (Time Series modality) in the healthcare domain. Primary AI use-case: Predictive Maintenance. Market signal: Global IoT Medical Devices market = $188.09 billion in 2026, projected to reach $767.52 billion by 2034, with a CAGR of 19.22% (2026-2034).. Investment score 64.7/100 (confidence 0.51). Recommended action: Data Sharing Agreement.

Teaser is public · premium is locked behind access.
Cardiofocus — Sensor Telemetry Dataset Opportunity — Dataset opportunity | d-nvest